ReviewScience progress2008
The epidemiological transition: the current status of infectious diseases in the developed world versus the developing world.
Review in Science progress, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
22 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Dietary Polyphenols-Important Non-Nutrients in the Prevention of Chronic Noncommunicable Diseases. A Systematic Review.Nutrients · 2019Pooled it
- Intracellular doppler spectroscopy of live tissue sentinels for a fast in-vitro bacterial infection assay.Scientific reports · 2025Article
- Quality and Accountability of ChatGPT in Health Care in Low- and Middle-Income Countries: Simulated Patient Study.Journal of medical Internet research · 2024Article
- The Need to Analyse Historical Mortality Data to Understand the Causes of Today's Health Inequalities.International journal of public health · 2024Article
- Article
- The miR-23-27-24 clusters drive lipid-associated macrophage proliferation in obese adipose tissue.Cell reports · 2023Article
- Community characteristics and the risk of non-communicable diseases in Ghana.PLOS global public health · 2023Article
- Reviewing the Past, Present, and Future Risks of Pathogens in Ghana and What This Means for Rethinking Infectious Disease Surveillance for Sub-Saharan Africa.Journal of tropical medicine · 2022Review
- A Typology of Poles' Attitudes toward COVID-19 during the First Wave of the Pandemic.International journal of environmental research and public health · 2021Article
- Epidemiological transition and double burden of diseases in low-income countries: the case of Mozambique.The Pan African medical journal · 2020Article
- Surgeons and preventative health: protocol for a mixed methods study of current practice, beliefs and attitudes influencing health promotion activities amongst public hospital surgeons.BMC health services research · 2018Article
- State of diagnosing infectious pathogens using colloidal nanomaterials.Biomaterials · 2017Review
- AIDS, Avian flu, SARS, MERS, Ebola, Zika… what next?Vaccine · 2017Review
- Global nursing in an Ebola viral haemorrhagic fever outbreak: before, during and after deployment.Global health action · 2017Article
- Infectious Gastroenteritis as a Risk Factor for Tropical Sprue and Malabsorption: A Case-Control Study.Digestive diseases and sciences · 2015Article
- Understanding the development and perception of global health for more effective student education.The Yale journal of biology and medicine · 2014Article
- The evolution of disease: anthropological perspectives on epidemiologic transitions.Global health action · 2014Article
- Beyond obesity and lifestyle: a review of 21st century chronic disease determinants.BioMed research international · 2014Review
- In search of a germ theory equivalent for chronic disease.Preventing chronic disease · 2012Article
- Triangulating on success: innovation, public health, medical care, and cause-specific US mortality rates over a half century (1950-2000).American journal of public health · 2010Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Wealthy, industrialized countries of the developed world successfully underwent the "epidemiologic transition" from infectious diseases to degenerative diseases, but developing countries have not yet achieved that transition. This article reviews the current status of Omran's Theory of Epidemiologic Transition, comparing the burden of infectious diseases in the developed world versus the developing world. The advent of modern sanitation and hygiene practices, effective vaccines, and antibiotics have significantly diminished the burden in the developed world, but infectious diseases remain the most common cause of death worldwide. The persistence of this disease burden has been due to a failure to employee effective strategies and to unforeseen developments, such as the emergence of HIV and the re-emergence of malaria and tuberculosis driven by newly developed drug resistance. The challenge in accurately assessing infectious disease burden and developing effective interventions is reviewed along with the most common diseases and current intervention strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.